Formulation and evaluation of Costus igneus herbal lollipops for diabetes management
DOI:
https://doi.org/10.56782/pps.308Keywords:
Costus igneus, Diabetes, Soxhlet extraction, herbal lollipopsAbstract
Objectives: This study aims to develop and evaluate the efficacy of herbal lollipops incorporating Costus igneus extract for diabetes management. Materials and Methods: The powdered Costus igneus material was subjected to extraction using ethanol by Soxhlet extraction method. The extract was filtered and concentrated under reduced pressure to obtain a concentrated extract. Various formulations of herbal lollipops were prepared using different concentrations of Costus igneus extract, along with suitable excipients like stevia, binder and colors. Results: The formulated lollipops showed the uniformity in weight and thickness. The hardness of all formulated lollipops was found within the standard range up to 9.65 to 10.50 kg/cm2. From the in-vitro drug release study, it was found that the formulations of lollipops containing corn syrup in the concentrations of 100, 90 and 80 mg showed the maximum drug release at 30 minutes. Among those formulations formulation F9 showed 100.6% of drug release. The in-vitro release kinetic study of the optimized formulation (F9) was found to be first order. The release of the dosage form follows the diffusion and dissolution mechanism and Non-Fickian diffusion mechanism. Conclusion: These findings suggest that herbal lollipops containing Costus igneus hold promise as a novel and effective alternative for managing diabetes.
Downloads
References
1. Shinde, S. P.; Kondhalkar, S. M. A review on insulin plant (Costus igneus L.) and its remedial approaches. Asian J. Res. Bot. 2025, 8(1), 14–21. DOI: 10.9734/ajrib/2025/v8i1238 DOI: https://doi.org/10.9734/ajrib/2025/v8i1238
2. Athilli, L.; Siddiqui, A. F.; Hussain, F.; Parvez, E. A. H. Pharmacognostic study and pharmacological potentials of Costus igneus plant – Review. Int. J. Pharmacogn. 2021, 8(12), 476–486. DOI: 10.13040/IJPSR.0975-8232.IJP.8(12).476-86 DOI: https://doi.org/10.13040/IJPSR.0975-8232.IJP.8(12).476-86
3. Laha, S.; Paul, S. Costus igneus – A therapeutic anti-diabetic herb with active phytoconstituents. Int. J. Pharm. Sci. Res. 2019, 10(8), 3583–3591. DOI: 10.13040/IJPSR.0975-8232.10(8).3583-91 DOI: https://doi.org/10.13040/IJPSR.0975-8232.10(8).3583-91
4. Shubham, K.; Mittal, A.; Babu, D.; Mittal, A. Herbal medicines for diabetes management and its secondary complications. Curr. Diabetes Rev. 2021, 17(4), 437–456. DOI: 10.2174/1573399816666201103143225 DOI: https://doi.org/10.2174/1573399816666201103143225
5. Azhagu Madhavan, S.; Ganesan, S.; Sripriya, R.; Priyadharshini, R. A literature review of anti-diabetic medicinal plant properties (Costus species). J. Biomed. Res. Environ. Sci. 2021, 2(5), 305–310. DOI: 10.37871/jbres1231 DOI: https://doi.org/10.37871/jbres1231
6. Khandale, S. N.; Sonavane, M. Potential therapeutic efficacy of Costus igneus for diabetes mellitus & other diseases with framework for its evaluation based on Ayurveda. Int. J. Adv. Res. 2019, 7(12), 813–818. DOI: 10.21474/IJAR01/10215 DOI: https://doi.org/10.21474/IJAR01/10215
7. Shivaprakash, G.; Thottacherry, E. D.; Rai, S.; Nandini, M.; Kumarachandra, R. Evaluation of antioxidant potential of Costus igneus in ethanol induced peroxidative damage in albino rats. J. Appl. Pharm. Sci. 2014, 4(8), 052–055. DOI: 10.7324/JAPS.2014.40810 DOI: https://doi.org/10.7324/JAPS.2014.40810
8. Vinotha, V.; Iswarya, A.; Thaya, R.; Govindarajan, M.; Alharbi, N. S.; Kadaikunnan, S.; et al. Synthesis of ZnO nanoparticles using insulin-rich leaf extract: Anti-diabetic, antibiofilm and antioxidant properties. J. Photochem. Photobiol. B: Biol. 2019, 197, Art. No: 111541. DOI: 10.1016/j.jphotobiol.2019.111541 DOI: https://doi.org/10.1016/j.jphotobiol.2019.111541
9. Talasila, E. G. K.; Bavirisetti, H.; Chimakurthy, J.; Candasamy, M. Effect of Costus igneus: The insulin plant, on pre-diabetes and diabetes in neonatal streptozotocin rats. J. Health Sci. 2014, 4(3), 162–168. DOI: 10.17532/jhsci.2014.163 DOI: https://doi.org/10.17532/jhsci.2014.163
10. Chandrakar, N.; Kaur, J.; Banerjee, M. Synergies of bioactivities, mechanisms, dietary factors and functional food applications of medicinal insulin plant (Costus pictus D.): A review. Int. J. Food Sci. Technol. 2024, 59, 8933–8942. DOI: 10.1111/ijfs.17588 DOI: https://doi.org/10.1111/ijfs.17588
11. Josephine, I. G.; Punnagai, K. In vitro cytotoxicity activity of ethanolic leaf extract of Costus igneus against hepatocellular carcinoma (HepG2) cells. Biomed. Pharmacol. J. 2024, 17, Art. No: 1715. DOI: 10.13005/bpj/1715 DOI: https://doi.org/10.13005/bpj/1715
12. Dhone, P. G.; Goyal, M.; Sahu, Y. P.; Mubeen, M. F. To evaluate antioxidant activity of Costus igneus in ethanol induced peroxidative damage in albino rats. Int. J. Health Sci. 2022, 6(S5), Art. No: 9858. DOI: 10.53730/ijhs.v6nS5.9858 DOI: https://doi.org/10.53730/ijhs.v6nS5.9858
13. Ratnakar, S. M; Prakash S. B. Phytochemical analysis of different solvent extracts of Costus igneus. Int. J. Food Nutrit. Sci. 2022, 11(12), 2364-2368
14. Jadhav, G.; Pagire, D.; Jadhav, V. Formulation and evaluation of anti-diabetic tablet from insulin plant (Costus igneus). Int. J. Multidiscip. Res. 2023, 5(3), Art. No: IJFMR23032976 DOI: https://doi.org/10.36948/ijfmr.2023.v05i03.2976
15. Prabhu, P. P.; Malli, R.; Koland, M.; Vijaynarayana, K.; D’Souza, U.; Harish, N. M.; Shastry, C. S.; Charyulu, R. N. Formulation and evaluation of fast dissolving films of levocetirizine dihydrochloride. Int. J. Pharm. Investig. 2011, 1(2), 99–104. DOI: 10.4103/2230-973X.82417 DOI: https://doi.org/10.4103/2230-973X.82417
16. Jacob, S.; Boddu, S. H. S.; Bhandare, R.; Shabbir, S. Orodispersible films: Current innovations and emerging trends. Pharmaceutics 2023, 15(12), Art. No: 2753. DOI: 10.3390/pharmaceutics15122753 DOI: https://doi.org/10.3390/pharmaceutics15122753
17. Alburyhi, M. M.; Noman, M. A.; Saif, A. A.; Mohamed, Y. A. S.; Hamidaddin, M. A.; Yahya, T. A. A.; Al-Ghorafi, M. A.; Abdullah, J. H. Lisinopril-excipient compatibility studies for advanced drug delivery systems development. World J. Pharm. Res. 2024, 13(16), 59–111. DOI: 10.20959/wjpr202416-33678
18. Singh, C.; Rao, K.; Yadav, N.; Bansal, N.; Vashist, Y.; Kumari, S.; Chugh, P. A review: Drug-excipient incompatibility by FTIR spectroscopy. Curr. Pharm. Anal. 2023, 19(5), 371–378. DOI: 10.2174/1573412919666230228102158 DOI: https://doi.org/10.2174/1573412919666230228102158
19. Alburyhi, M. M.; Noman, M. A.; Saif, A. A.; Hamidaddin, M. A.; Yahya, T.A.A.; Abd-hafiz Al-Ghorafi, M.A. Rosuvastatin-excipient compatibility studies for advanced drug delivery systems development. World J. Pharm. Res. 2024, 13(13), 1549–1582. DOI: 10.20959/wjpr202413-33126
20. Vijaya, V.; Karunai Selvi, B. K.; Arockia John, P.J.; Ramya, S.; Jayakumararaj, R. Phytochemical screening, GC-MS and FTIR analysis of bioactive compounds in methanolic leaf extracts of Costus igneus (CIMLE) as a natural source of drug lead molecules for next-generation drug-design, development and therapeutics. J. Drug Deliv. Ther. 2022, 12(5-S), 142–155. DOI: 10.22270/jddt.v12i5-s.5658 DOI: https://doi.org/10.22270/jddt.v12i5-S.5658
21. Muthukumar, C.; Cathrine, L.; Gurupriya, S. Qualitative and quantitative phytochemical analysis of Costus igneus leaf extract. J. Pharmacogn. Phytochem. 2019, 8(4), 1595–1598.
22. Bharathi, J. K.; Prakash, M. A. S. Phytochemical screening and quantitative analysis, FTIR and GC-MS analysis of Costus pictus D. Don ex Lindl. leaf extracts – A potential therapeutic herb. J. Indian Chem. Soc. 2024, 101(11), Art. No: 101362. DOI: 10.1016/j.jics.2024.101362 DOI: https://doi.org/10.1016/j.jics.2024.101362
23. Khandagale Sandip Suresh, Mahalkar Ram Babasaheb, Madane Somnath Jotiram, Patil Onkar Ganpat, Dabhade Sakshi kailasrao, Salve Dvitiya Shantilal. To study the preparation, formulation and evaluation of medicated lollipop. Int. J. Pharm. Sci. 2024, 2(5), 1275–1291. DOI: 10.5281/zenodo.11264459
24. Rao, N. B.; Gajula, R. G.; Sujatha, E.; Kumari, O. S. Phytochemical analysis and anti-microbial activity of Costus igneus (insulin plant) leaf extract. Int. J. Biol. Pharm. Allied Sci. 2016, 5(6), 1207–1214.
25. Bedse, A.; Nalawade, A.; Dhamane, S.; Kachave, R. N.; Wagh, V.; Tare, H.; Ghangale, G. Formulation and evaluation of herbal remedy for cough. Int. J. Pharm. Qual. Assur. 2023, 14(3), 762–766. DOI: 10.25258/ijpqa.14.3.51. DOI: https://doi.org/10.25258/ijpqa.14.3.51
26. Cunha, F. A. B.; Matias, E. F. F.; Brito, S. V.; Ferreira, F. S.; Braga, J. M. A.; Costa, J. G. M.; Coutinho, H. D. M. Phytochemical screening, antibacterial activity and in vitro interactions between Costus cf. arabicus L. with UV-A and aminoglycosides. Nat. Prod. Res. 2012, 26(4), 380–386. DOI: 10.1080/14786419.2010.545776. DOI: https://doi.org/10.1080/14786419.2010.545776
27. Sahoo, M. R.; Srinivasan, U. M.; Varier, R. R. Development and evaluation of Talisapatradi and Vyoshadi Choorna lozenges—An Ayurvedic traditional formulation. J. Rep. Pharm. Sci. 2022, 11(1), 110–117. DOI: 10.4103/jrptps.JRPTPS_80_21. DOI: https://doi.org/10.4103/jrptps.JRPTPS_80_21
28. Chowdary, A. R.; Raaththika, R.; Vijayalakshmi, P. Evaluation of the cookies formulated with Costus igneus plant material for antidiabetic activity. Medico-Legal Update 2020, 20(3), 265-271.
29. Choppala, P. B.; Gera, V. N.; Inakoti, R. K.; Malakondaiah, G. Costus igneus oro-herbal films: Innovative and cost-effective therapy. Int. J. Food Nutr. Sci. 2022, 11(11), 3962-3974.
30. Ding, Y.; Chu, N.-n.; Wang, R.; Qin, W.; Shi, Y.-f.; Qian, Z.-z.; Liu, B.; He, Q. Pharmacokinetic and pharmacodynamic evaluation study of etomidate: a randomized, open-label, 2-period crossover study in healthy Chinese subjects. Sci. Rep. 2024, 14, Art. No: 7071. DOI: 10.1038/s41598-024-57581-2. DOI: https://doi.org/10.1038/s41598-024-57581-2
31. Hock, F. J.; Gralinski, M. R. (Eds.). Drug Discovery and Evaluation: Methods in Clinical Pharmacology, Living Reference Work; Springer Nature: 2020. DOI: https://doi.org/10.1007/978-3-319-56637-5
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Saidatri Arige, Lakshmana Rao A, Vinod Kumar V.L, Devika M, Veena Sree P P, Rama Krishna T.P
This work is licensed under a Creative Commons Attribution 4.0 International License.
For all articles published in Prospects in Pharmaceutical Sciences copyright is retained by the authors. The journal publishes articles in the Open Access policy, within the CC BY 4.0 licence.
This is a human-readable summary of (and not a substitute for) the license. Disclaimer.
You are free to:
Share — copy and redistribute the material in any medium or format
Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
How to Cite
